Investing.com - Financial Markets Worldwide

Kyongbo Pharmaceutical Co Ltd (214390)

Seoul
Currency in KRW
5,020
-40(-0.79%)
Closed·
214390 Scorecard
Full Analysis
Operates with a significant debt burden
214390 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
4,9955,070
52 wk Range
4,7557,500
Key Statistics
Edit
Bid/Ask
5,020.00 / 5,030.00
Prev. Close
5,060
Open
5,070
Day's Range
4,995-5,070
52 wk Range
4,755-7,500
Volume
12.95K
Average Volume (3m)
25.66K
1-Year Change
-32.53%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
214390 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 9
Trading at a low Price / Book multiple
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Kyongbo Pharmaceutical Co Ltd Company Profile

Kyongbo Pharmaceutical Co., Ltd manufactures and sells active pharmaceutical ingredients and finished drugs in South Korea and internationally. The company offers general, cephalosporins, and anti-cancer APIs; prescription drugs, including anesthetic, cardiovascular, digestive, and antibiotics; and OTC drugs. It also provides medical devices, including portable X-ray machine and ultrasonic diagnostic equipment; and extraporeal shockwave therapy and temperature control PROBE. In addition, the company is involved in CDMO business; and research and development of Clopidogrel cardiovascular drug, Imatinlb anticancer drug, Donepezil anti-psychotic drug, Entecavir for anti-virus and infectious disease, and Esomeprazole. It also exports its products. The company was formerly known as Kyongbo Chemical Co. Ltd. and changed its name to Kyongbo Pharmaceutical Co., Ltd in March 2002. Kyongbo Pharmaceutical Co., Ltd was founded in 1987 and is headquartered in Asan-si, South Korea.

Industry
Pharmaceuticals
Sector
Healthcare
0
Market
South Korea

Compare 214390 to Peers and Sector

Metrics to compare
214390
Peers
Sector
Relationship
P/E Ratio
52.3x0.8x−0.5x
PEG Ratio
−0.92−0.100.00
Price/Book
0.8x0.8x2.6x
Price / LTM Sales
0.5x0.7x3.3x
Upside (Analyst Target)
-28.6%43.4%
Fair Value Upside
Unlock16.6%7.1%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 95.99%
Dividend Yield
1.00%
Industry Median 0.93%
Annualised payout
50.00
Paid annually
5-Years Growth
-
Growth Streak
Unlock

Earnings

Latest Release
May 15, 2025
EPS / Forecast
-29.00 / --
Revenue / Forecast
60.59B / --
EPS Revisions
a
a
Unlock
Last 90 days

214390 Income Statement

FAQ

What Stock Exchange Does Kyongbo Pharmaceutical Co Ltd Trade On?

Kyongbo Pharmaceutical Co Ltd is listed and trades on the Seoul Stock Exchange stock exchange.

What Is the Stock Symbol for Kyongbo Pharmaceutical Co Ltd?

The stock symbol for Kyongbo Pharmaceutical Co Ltd is "214390."

What Is the Kyongbo Pharmaceutical Co Ltd Market Cap?

As of today, Kyongbo Pharmaceutical Co Ltd market cap is 120.01B.

What Is Kyongbo Pharmaceutical Co Ltd's Earnings Per Share (TTM)?

The Kyongbo Pharmaceutical Co Ltd EPS (TTM) is 95.99.

From a Technical Analysis Perspective, Is 214390 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Kyongbo Pharmaceutical Co Ltd Stock Split?

Kyongbo Pharmaceutical Co Ltd has split 0 times.

How Many Employees Does Kyongbo Pharmaceutical Co Ltd Have?

Kyongbo Pharmaceutical Co Ltd has 0 employees.

What is the current trading status of Kyongbo Pharmaceutical Co Ltd (214390)?

As of 10 Aug 2025, Kyongbo Pharmaceutical Co Ltd (214390) is trading at a price of 5,020.00, with a previous close of 5,060.00. The stock has fluctuated within a day range of 4,995.00 to 5,070.00, while its 52-week range spans from 4,755.00 to 7,500.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.